GTR Home > Tests > Search results - C2751831[DISCUI]

Apply filters

Showing tests for all 1016 conditions

Compare labs

  • Hide states

GTR test search results for C2751831[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 27 tests for 1016 conditions in 13 labs

CAllNeuro panel

Lab: Centogene AG - the Rare Disease Company University of Rostock Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (602)
Total targets (1038)

CMyofibrillar Myopathy Panel (8 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (20)
Total targets (8)

CMyoGene Panel (43 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (95)
Total targets (43)

CMyopathy, myofibrillar 6

Lab: Centogene AG - the Rare Disease Company University of Rostock Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CPan Cardiomyopathy Panel (62 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (103)
Total targets (62)

CDCM/Arrhythmogenic Cardiomyopathy Panel (53 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (97)
Total targets (53)

CMyofibrillar Myopathy Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (11)
Total targets (8)

CDistal Hereditary Myopathy NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (20)
Total targets (18)

CMyofibrillar Myopathy, Childhood Onset via the BAG3 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CBAG3

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (34)

CMyofibrillar myopathy

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (23)
Total targets (13)

CNeuromuscular Disorders Sequencing Panel

Lab: Genetic Services Laboratory University of Chicago Chicago, Illinois, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (99)
Total targets (88)

CRestrictive Cardiomyopathy NGS Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (32)
Total targets (10)

CMyopathy, myofibrillar 6 (sequence analysis of BAG3 gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

CCongenital and Distal Myopathies Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (52)
Total targets (73)

CCardiomyopathy, restrictive Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (5)
Total targets (7)

CBAG3

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CHypertrophic Cardiomyopathy NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (150)
Total targets (63)

CMyofibrillar Myopathy NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (20)
Total targets (8)

CMyofibrillar Myopathy (MFM) Evaluation

Lab: Athena Diagnostics Inc Quest Diagnostics Marlborough, Massachusetts, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (6)
Total targets (6)

Showing 1 to 20 of 27 tests for 1016 conditions in 13 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.